Indoco Remedies share news, announcements and annual reports
NSE: INDOCOBSE: 532612Pharmaceuticals & BiotechnologySmall Cap
Indoco Remedies Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2005
Last close ₹213.75down ₹6.90 (3.13%)BSE ₹214.05
Share price at the NSE close on 28 Oct 2026. Previous close ₹220.65.
28 Oct: open ₹219.20, high ₹220.40, low ₹211.25
52-week range of traded prices to 28 Oct 2026
₹162.19Low, 30 Mar 2026₹288.00High, 6 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,973 Cr1,173rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 61.77
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹132 crore of one-off items, the largest of them in the quarter to Jun 2026.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.93
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.09%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 3.2%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹132 crore of one-off items, the largest of them in the quarter to Jun 2026.
- −10.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.96
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,82,27841.5% delivered
Indoco Remedies board and management
28 filed, newest first.
Jul 2026
Mar 2026
31 Mar · Management
May 2025
22 May · Management
Mar 2025
Mar 2024
29 Mar · Management
Jan 2024
May 2023
Nov 2022
May 2022
17 May · Management
Nov 2021
Jun 2021
Oct 2020
Mar 2020
Jan 2019
23 Jan · Management
May 2018
30 May · Management
Aug 2017
17 Aug · Management
Jan 2017
Aug 2014
7 Aug · Management
May 2013
Dec 2011
21 Dec · Management
Board of Directors at their meeting held on December 17, 2011 accepted the resignation of Mr. D. N. Mungale, as Director of the Company, with effect from December 09, 2011.
Oct 2010
22 Oct · Management
At the meeting of the Board of Directors held on October 20, 2010, the letter dated July 30, 2010 received from Mr. F. X. Coutinho tendering his resignation as the Wholetime Director-Marketing of the Company was considered and after due consideration it was decided to accept his resignation with effect from October 20, 2010. It was also decided that the vacancy caused by the resignation of Mr. Coutinho be not filled and the marketing function be overseen by Ms. Aditi Kare Panandikar.
Feb 2008
25 Feb · Management
Vide its letter dated February 23, 2008 that "The meeting of the Board of Directors of the Company held today, the Board has accepted the resignation of Mr. Atul S. Rajadhyaksha as Director w.e.f. 23.02.08 and has appointed Mr. Sharad P. Upasani as the Director w.e.f. 23.02.08 in the vacancy caused by the resignation of Mr. Atul S. Rajadhyaksha".
May 2007
17 May · Management
Mr. J. B. Salian has been appointed the Secretary of the Company w.e.f. 9th May 2007 in place of Mr. Anil Kale, who has left the employment with the Company.
Apr 2007
26 Apr · Management
April 26, 2007 that "at the just concluded meeting of the Board of Directors of the Company, the following items, inter-alia, were transacted; (1) The resignations of the following directors from the Board, were accepted; (a) Mr.S.Y.Rege. (b) Mr.P.K.Kakodkar. (2) The following persons were appointed as Additional Directors on the Board in terms of the provisions of Section 260 of the Companies Act, 1956. (i) Mr. Atul Rajadhyaksha (ii) Mr. Rajiv Kakodkar".